Structure

Physi-Chem Properties

Molecular Weight:  400.33
Volume:  453.63
LogP:  5.97
LogD:  5.481
LogS:  -5.455
# Rotatable Bonds:  5
TPSA:  37.3
# H-Bond Aceptor:  2
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  2

MedChem Properties

QED Drug-Likeness Score:  0.53
Synthetic Accessibility Score:  4.284
Fsp3:  0.889
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.656
MDCK Permeability:  1.3795247468806338e-05
Pgp-inhibitor:  0.971
Pgp-substrate:  0.161
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.994
30% Bioavailability (F30%):  0.77

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.492
Plasma Protein Binding (PPB):  94.07122039794922%
Volume Distribution (VD):  1.327
Pgp-substrate:  1.2172695398330688%

ADMET: Metabolism

CYP1A2-inhibitor:  0.131
CYP1A2-substrate:  0.604
CYP2C19-inhibitor:  0.13
CYP2C19-substrate:  0.924
CYP2C9-inhibitor:  0.309
CYP2C9-substrate:  0.258
CYP2D6-inhibitor:  0.046
CYP2D6-substrate:  0.862
CYP3A4-inhibitor:  0.609
CYP3A4-substrate:  0.519

ADMET: Excretion

Clearance (CL):  8.241
Half-life (T1/2):  0.216

ADMET: Toxicity

hERG Blockers:  0.28
Human Hepatotoxicity (H-HT):  0.325
Drug-inuced Liver Injury (DILI):  0.585
AMES Toxicity:  0.006
Rat Oral Acute Toxicity:  0.013
Maximum Recommended Daily Dose:  0.683
Skin Sensitization:  0.916
Carcinogencity:  0.358
Eye Corrosion:  0.043
Eye Irritation:  0.191
Respiratory Toxicity:  0.957

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC59453

Natural Product ID:  NPC59453
Common Name*:   3-Beta-Hydroxycholest-5-En-24-One
IUPAC Name:   (6R)-6-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptan-3-one
Synonyms:  
Standard InCHIKey:  PGLNLCWHYQYRGQ-ZHHJOTBYSA-N
Standard InCHI:  InChI=1S/C27H44O2/c1-17(2)25(29)11-6-18(3)22-9-10-23-21-8-7-19-16-20(28)12-14-26(19,4)24(21)13-15-27(22,23)5/h7,17-18,20-24,28H,6,8-16H2,1-5H3/t18-,20+,21+,22-,23+,24+,26+,27-/m1/s1
SMILES:  O[C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]2([C@H]3CC[C@@H]2[C@@H](CCC(=O)C(C)C)C)C)C1)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL275911
PubChem CID:   11036808
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0001445] Bile acids, alcohols and derivatives
          • [CHEMONTID:0002194] Hydroxy bile acids, alcohols and derivatives
            • [CHEMONTID:0000260] Monohydroxy bile acids, alcohols and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO12354 Sargassum pallidum Species Sargassaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO25840 Sargassum fusiforme Species Sargassaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO25840 Sargassum fusiforme Species Sargassaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO4145 Hijikia fusiforme n.a. n.a. n.a. n.a. n.a. n.a. Database[TM-MC]
NPO12354 Sargassum pallidum Species Sargassaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO25840 Sargassum fusiforme Species Sargassaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO12354 Sargassum pallidum Species Sargassaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1794 Individual Protein LXR-alpha Homo sapiens EC50 = 180.0 nM PMID[513244]
NPT1794 Individual Protein LXR-alpha Homo sapiens RE = 1.3 n.a. PMID[513244]
NPT1794 Individual Protein LXR-alpha Homo sapiens FC = 2.36 n.a. PMID[513246]
NPT312 Organism Saccharomyces cerevisiae Saccharomyces cerevisiae IC50 > 8000.0 ug.mL-1 PMID[513245]
NPT26790 SINGLE PROTEIN Oxysterols receptor LXR-beta Rattus norvegicus FC = 3.85 n.a. PMID[513246]
NPT2 Others Unspecified Ratio = 1.63 n.a. PMID[513246]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC59453 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC221758
0.975 High Similarity NPC474733
0.975 High Similarity NPC51014
0.975 High Similarity NPC474732
0.975 High Similarity NPC474778
0.975 High Similarity NPC31564
0.975 High Similarity NPC145879
0.9744 High Similarity NPC151519
0.963 High Similarity NPC475740
0.963 High Similarity NPC58063
0.9512 High Similarity NPC328313
0.9506 High Similarity NPC155011
0.95 High Similarity NPC214043
0.95 High Similarity NPC82902
0.95 High Similarity NPC85774
0.9398 High Similarity NPC32830
0.9398 High Similarity NPC186688
0.9398 High Similarity NPC76879
0.9398 High Similarity NPC31985
0.9398 High Similarity NPC26959
0.9398 High Similarity NPC474245
0.9398 High Similarity NPC268406
0.9398 High Similarity NPC1015
0.9383 High Similarity NPC474218
0.9383 High Similarity NPC471224
0.9383 High Similarity NPC469948
0.9375 High Similarity NPC476082
0.9375 High Similarity NPC278648
0.9286 High Similarity NPC48010
0.9277 High Similarity NPC53911
0.9277 High Similarity NPC471722
0.9268 High Similarity NPC118648
0.9268 High Similarity NPC475022
0.9268 High Similarity NPC20688
0.9268 High Similarity NPC222613
0.9268 High Similarity NPC469994
0.9259 High Similarity NPC473246
0.9259 High Similarity NPC472265
0.9167 High Similarity NPC309603
0.9167 High Similarity NPC473999
0.9157 High Similarity NPC474684
0.9157 High Similarity NPC90652
0.9157 High Similarity NPC142361
0.9157 High Similarity NPC317590
0.9146 High Similarity NPC470574
0.9146 High Similarity NPC202868
0.9146 High Similarity NPC474083
0.9048 High Similarity NPC328539
0.9048 High Similarity NPC470417
0.9048 High Similarity NPC193360
0.9036 High Similarity NPC473168
0.9036 High Similarity NPC72133
0.9036 High Similarity NPC94755
0.9024 High Similarity NPC180834
0.9024 High Similarity NPC33913
0.9024 High Similarity NPC329043
0.9024 High Similarity NPC58841
0.9024 High Similarity NPC161423
0.9024 High Similarity NPC227064
0.9024 High Similarity NPC237712
0.9024 High Similarity NPC321187
0.9 High Similarity NPC2482
0.9 High Similarity NPC472478
0.8987 High Similarity NPC82635
0.8974 High Similarity NPC321381
0.8974 High Similarity NPC107059
0.8974 High Similarity NPC321016
0.8966 High Similarity NPC245972
0.8966 High Similarity NPC196485
0.8953 High Similarity NPC475806
0.8953 High Similarity NPC272746
0.8953 High Similarity NPC473998
0.8941 High Similarity NPC86319
0.8941 High Similarity NPC474704
0.8941 High Similarity NPC477943
0.8941 High Similarity NPC119416
0.8941 High Similarity NPC475921
0.8941 High Similarity NPC275740
0.8941 High Similarity NPC2983
0.8929 High Similarity NPC472482
0.8929 High Similarity NPC96496
0.8929 High Similarity NPC159046
0.8929 High Similarity NPC233836
0.8929 High Similarity NPC472481
0.8929 High Similarity NPC187376
0.8929 High Similarity NPC472484
0.8929 High Similarity NPC93778
0.8889 High Similarity NPC147066
0.8889 High Similarity NPC14151
0.8875 High Similarity NPC215843
0.8864 High Similarity NPC469599
0.8861 High Similarity NPC318495
0.8861 High Similarity NPC155986
0.8861 High Similarity NPC198968
0.8851 High Similarity NPC475255
0.8851 High Similarity NPC12722
0.8851 High Similarity NPC474736
0.8846 High Similarity NPC288035
0.8846 High Similarity NPC304309
0.8846 High Similarity NPC28657
0.8846 High Similarity NPC162742
0.8846 High Similarity NPC230301
0.8846 High Similarity NPC22105
0.8846 High Similarity NPC136188
0.8846 High Similarity NPC285893
0.8846 High Similarity NPC134847
0.8837 High Similarity NPC85173
0.8837 High Similarity NPC320026
0.8837 High Similarity NPC171441
0.8837 High Similarity NPC191684
0.8837 High Similarity NPC69622
0.8837 High Similarity NPC126993
0.8824 High Similarity NPC471724
0.8824 High Similarity NPC143767
0.8824 High Similarity NPC242864
0.8824 High Similarity NPC131470
0.881 High Similarity NPC89077
0.881 High Similarity NPC327115
0.881 High Similarity NPC55309
0.881 High Similarity NPC28252
0.8795 High Similarity NPC25833
0.8795 High Similarity NPC165064
0.878 High Similarity NPC212083
0.878 High Similarity NPC48362
0.878 High Similarity NPC328351
0.878 High Similarity NPC310989
0.878 High Similarity NPC260956
0.8765 High Similarity NPC164999
0.875 High Similarity NPC292793
0.875 High Similarity NPC474216
0.875 High Similarity NPC8993
0.875 High Similarity NPC111015
0.875 High Similarity NPC477522
0.875 High Similarity NPC87604
0.875 High Similarity NPC473943
0.8736 High Similarity NPC189520
0.8736 High Similarity NPC110657
0.8736 High Similarity NPC168027
0.8736 High Similarity NPC131872
0.8736 High Similarity NPC212301
0.8736 High Similarity NPC154101
0.8736 High Similarity NPC185936
0.8736 High Similarity NPC262870
0.8736 High Similarity NPC86266
0.8734 High Similarity NPC300324
0.8734 High Similarity NPC113733
0.8734 High Similarity NPC240604
0.8721 High Similarity NPC128496
0.8721 High Similarity NPC84271
0.8721 High Similarity NPC102414
0.8721 High Similarity NPC77168
0.8706 High Similarity NPC136548
0.8706 High Similarity NPC141292
0.8706 High Similarity NPC73064
0.869 High Similarity NPC133954
0.869 High Similarity NPC197823
0.8675 High Similarity NPC470046
0.8675 High Similarity NPC470047
0.8675 High Similarity NPC475726
0.8675 High Similarity NPC472743
0.8667 High Similarity NPC108078
0.8667 High Similarity NPC190554
0.8659 High Similarity NPC121984
0.8659 High Similarity NPC136150
0.8659 High Similarity NPC3915
0.8659 High Similarity NPC38350
0.8659 High Similarity NPC201912
0.8652 High Similarity NPC271195
0.8652 High Similarity NPC127063
0.8642 High Similarity NPC47982
0.8642 High Similarity NPC143182
0.8642 High Similarity NPC84694
0.8642 High Similarity NPC472490
0.8642 High Similarity NPC81306
0.8642 High Similarity NPC477371
0.8642 High Similarity NPC109546
0.8642 High Similarity NPC328714
0.8642 High Similarity NPC201459
0.8642 High Similarity NPC28862
0.8636 High Similarity NPC470376
0.8636 High Similarity NPC472942
0.8636 High Similarity NPC470224
0.8636 High Similarity NPC109305
0.8636 High Similarity NPC170220
0.8636 High Similarity NPC250575
0.8636 High Similarity NPC141497
0.8636 High Similarity NPC470375
0.8636 High Similarity NPC107674
0.8636 High Similarity NPC69454
0.8625 High Similarity NPC34019
0.8621 High Similarity NPC471896
0.8621 High Similarity NPC183283
0.8608 High Similarity NPC141071
0.8608 High Similarity NPC257347
0.8608 High Similarity NPC471723
0.8605 High Similarity NPC44181
0.8605 High Similarity NPC472483
0.8605 High Similarity NPC474677
0.8605 High Similarity NPC292491
0.8605 High Similarity NPC310752

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC59453 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
1.0 High Similarity NPD4786 Approved
0.9744 High Similarity NPD3667 Approved
0.9167 High Similarity NPD5328 Approved
0.9036 High Similarity NPD3618 Phase 1
0.9024 High Similarity NPD3666 Approved
0.9024 High Similarity NPD3665 Phase 1
0.9024 High Similarity NPD3133 Approved
0.8953 High Similarity NPD6079 Approved
0.8851 High Similarity NPD6399 Phase 3
0.8846 High Similarity NPD6942 Approved
0.8846 High Similarity NPD7339 Approved
0.8795 High Similarity NPD3668 Phase 3
0.8636 High Similarity NPD4202 Approved
0.8588 High Similarity NPD5279 Phase 3
0.8554 High Similarity NPD4221 Approved
0.8554 High Similarity NPD4223 Phase 3
0.8506 High Similarity NPD4753 Phase 2
0.85 High Similarity NPD3701 Clinical (unspecified phase)
0.8471 Intermediate Similarity NPD5329 Approved
0.8353 Intermediate Similarity NPD4197 Approved
0.8352 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.8352 Intermediate Similarity NPD5221 Approved
0.8352 Intermediate Similarity NPD5222 Approved
0.8352 Intermediate Similarity NPD4697 Phase 3
0.8261 Intermediate Similarity NPD5173 Approved
0.8261 Intermediate Similarity NPD4755 Approved
0.8256 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.8235 Intermediate Similarity NPD4788 Approved
0.8161 Intermediate Similarity NPD4138 Approved
0.8161 Intermediate Similarity NPD7521 Approved
0.8161 Intermediate Similarity NPD6409 Approved
0.8161 Intermediate Similarity NPD4693 Phase 3
0.8161 Intermediate Similarity NPD5330 Approved
0.8161 Intermediate Similarity NPD4688 Approved
0.8161 Intermediate Similarity NPD4689 Approved
0.8161 Intermediate Similarity NPD7146 Approved
0.8161 Intermediate Similarity NPD6684 Approved
0.8161 Intermediate Similarity NPD7334 Approved
0.8161 Intermediate Similarity NPD4690 Approved
0.8161 Intermediate Similarity NPD5205 Approved
0.8111 Intermediate Similarity NPD7515 Phase 2
0.8095 Intermediate Similarity NPD7525 Registered
0.8085 Intermediate Similarity NPD5286 Approved
0.8085 Intermediate Similarity NPD4700 Approved
0.8085 Intermediate Similarity NPD4696 Approved
0.8085 Intermediate Similarity NPD5285 Approved
0.8072 Intermediate Similarity NPD3617 Approved
0.8065 Intermediate Similarity NPD6083 Phase 2
0.8065 Intermediate Similarity NPD6084 Phase 2
0.8043 Intermediate Similarity NPD5210 Approved
0.8043 Intermediate Similarity NPD4629 Approved
0.8025 Intermediate Similarity NPD6924 Approved
0.8025 Intermediate Similarity NPD6926 Approved
0.8 Intermediate Similarity NPD4809 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD4808 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD5223 Approved
0.7978 Intermediate Similarity NPD5737 Approved
0.7978 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7978 Intermediate Similarity NPD6672 Approved
0.7978 Intermediate Similarity NPD6903 Approved
0.7955 Intermediate Similarity NPD5690 Phase 2
0.7955 Intermediate Similarity NPD4694 Approved
0.7955 Intermediate Similarity NPD5280 Approved
0.7917 Intermediate Similarity NPD5224 Approved
0.7917 Intermediate Similarity NPD5226 Approved
0.7917 Intermediate Similarity NPD5225 Approved
0.7917 Intermediate Similarity NPD4633 Approved
0.7917 Intermediate Similarity NPD5211 Phase 2
0.7882 Intermediate Similarity NPD4695 Discontinued
0.7875 Intermediate Similarity NPD4747 Approved
0.7857 Intermediate Similarity NPD6675 Approved
0.7857 Intermediate Similarity NPD6402 Approved
0.7857 Intermediate Similarity NPD5739 Approved
0.7857 Intermediate Similarity NPD7128 Approved
0.7835 Intermediate Similarity NPD5175 Approved
0.7835 Intermediate Similarity NPD5174 Approved
0.7835 Intermediate Similarity NPD4754 Approved
0.7831 Intermediate Similarity NPD6933 Approved
0.7805 Intermediate Similarity NPD4785 Approved
0.7805 Intermediate Similarity NPD4784 Approved
0.7791 Intermediate Similarity NPD4692 Approved
0.7791 Intermediate Similarity NPD4139 Approved
0.7778 Intermediate Similarity NPD7151 Approved
0.7778 Intermediate Similarity NPD7150 Approved
0.7778 Intermediate Similarity NPD7152 Approved
0.7778 Intermediate Similarity NPD4243 Approved
0.7765 Intermediate Similarity NPD4195 Approved
0.7755 Intermediate Similarity NPD5141 Approved
0.7753 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7753 Intermediate Similarity NPD6098 Approved
0.775 Intermediate Similarity NPD3700 Clinical (unspecified phase)
0.775 Intermediate Similarity NPD4137 Phase 3
0.775 Intermediate Similarity NPD3699 Clinical (unspecified phase)
0.775 Intermediate Similarity NPD6923 Approved
0.775 Intermediate Similarity NPD6922 Approved
0.7742 Intermediate Similarity NPD7748 Approved
0.77 Intermediate Similarity NPD7320 Approved
0.77 Intermediate Similarity NPD6881 Approved
0.77 Intermediate Similarity NPD6899 Approved
0.7692 Intermediate Similarity NPD3171 Clinical (unspecified phase)
0.7677 Intermediate Similarity NPD4767 Approved
0.7677 Intermediate Similarity NPD4768 Approved
0.7667 Intermediate Similarity NPD4751 Clinical (unspecified phase)
0.766 Intermediate Similarity NPD5695 Phase 3
0.7654 Intermediate Similarity NPD4691 Approved
0.7654 Intermediate Similarity NPD4789 Approved
0.7654 Intermediate Similarity NPD7144 Approved
0.7654 Intermediate Similarity NPD4245 Approved
0.7654 Intermediate Similarity NPD4244 Approved
0.7654 Intermediate Similarity NPD7143 Approved
0.7625 Intermediate Similarity NPD3621 Clinical (unspecified phase)
0.7624 Intermediate Similarity NPD6372 Approved
0.7624 Intermediate Similarity NPD6373 Approved
0.7604 Intermediate Similarity NPD5696 Approved
0.76 Intermediate Similarity NPD5701 Approved
0.76 Intermediate Similarity NPD5697 Approved
0.759 Intermediate Similarity NPD6113 Clinical (unspecified phase)
0.759 Intermediate Similarity NPD5733 Approved
0.7558 Intermediate Similarity NPD7645 Phase 2
0.7558 Intermediate Similarity NPD6929 Approved
0.7556 Intermediate Similarity NPD4623 Approved
0.7556 Intermediate Similarity NPD4519 Discontinued
0.7549 Intermediate Similarity NPD7290 Approved
0.7549 Intermediate Similarity NPD6883 Approved
0.7549 Intermediate Similarity NPD7102 Approved
0.7531 Intermediate Similarity NPD3698 Phase 2
0.7527 Intermediate Similarity NPD8034 Phase 2
0.7527 Intermediate Similarity NPD5281 Approved
0.7527 Intermediate Similarity NPD5284 Approved
0.7527 Intermediate Similarity NPD8035 Phase 2
0.7525 Intermediate Similarity NPD4730 Approved
0.7525 Intermediate Similarity NPD6011 Approved
0.7525 Intermediate Similarity NPD5168 Approved
0.7525 Intermediate Similarity NPD4729 Approved
0.7525 Intermediate Similarity NPD5128 Approved
0.75 Intermediate Similarity NPD7902 Approved
0.75 Intermediate Similarity NPD6904 Approved
0.75 Intermediate Similarity NPD6080 Approved
0.75 Intermediate Similarity NPD6673 Approved
0.7476 Intermediate Similarity NPD6650 Approved
0.7476 Intermediate Similarity NPD6617 Approved
0.7476 Intermediate Similarity NPD6869 Approved
0.7476 Intermediate Similarity NPD6649 Approved
0.7476 Intermediate Similarity NPD6847 Approved
0.7476 Intermediate Similarity NPD8130 Phase 1
0.7476 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD6930 Phase 2
0.7471 Intermediate Similarity NPD6931 Approved
0.7471 Intermediate Similarity NPD4748 Discontinued
0.7451 Intermediate Similarity NPD6014 Approved
0.7451 Intermediate Similarity NPD6012 Approved
0.7451 Intermediate Similarity NPD6013 Approved
0.7442 Intermediate Similarity NPD5784 Clinical (unspecified phase)
0.7426 Intermediate Similarity NPD6412 Phase 2
0.7423 Intermediate Similarity NPD7638 Approved
0.7419 Intermediate Similarity NPD4096 Approved
0.7412 Intermediate Similarity NPD6117 Approved
0.7407 Intermediate Similarity NPD5361 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD5360 Phase 3
0.7404 Intermediate Similarity NPD8297 Approved
0.7404 Intermediate Similarity NPD6882 Approved
0.7391 Intermediate Similarity NPD4518 Approved
0.7391 Intermediate Similarity NPD5208 Approved
0.7381 Intermediate Similarity NPD4058 Approved
0.7381 Intermediate Similarity NPD4687 Approved
0.7379 Intermediate Similarity NPD5251 Approved
0.7379 Intermediate Similarity NPD5247 Approved
0.7379 Intermediate Similarity NPD5249 Phase 3
0.7379 Intermediate Similarity NPD5134 Clinical (unspecified phase)
0.7379 Intermediate Similarity NPD5248 Approved
0.7379 Intermediate Similarity NPD5135 Approved
0.7379 Intermediate Similarity NPD5169 Approved
0.7379 Intermediate Similarity NPD5250 Approved
0.7379 Intermediate Similarity NPD4634 Approved
0.7349 Intermediate Similarity NPD5276 Approved
0.7347 Intermediate Similarity NPD7640 Approved
0.7347 Intermediate Similarity NPD7639 Approved
0.7326 Intermediate Similarity NPD5776 Phase 2
0.7326 Intermediate Similarity NPD6932 Approved
0.7326 Intermediate Similarity NPD6925 Approved
0.7326 Intermediate Similarity NPD6116 Phase 1
0.7312 Intermediate Similarity NPD7285 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD5216 Approved
0.7308 Intermediate Similarity NPD5217 Approved
0.7308 Intermediate Similarity NPD5215 Approved
0.7308 Intermediate Similarity NPD5127 Approved
0.7294 Intermediate Similarity NPD4190 Phase 3
0.7294 Intermediate Similarity NPD3703 Phase 2
0.7294 Intermediate Similarity NPD5275 Approved
0.7292 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD7115 Discovery
0.7273 Intermediate Similarity NPD7509 Discontinued
0.7263 Intermediate Similarity NPD5133 Approved
0.7241 Intermediate Similarity NPD7145 Approved
0.7241 Intermediate Similarity NPD6115 Approved
0.7241 Intermediate Similarity NPD6114 Approved
0.7241 Intermediate Similarity NPD6697 Approved
0.7241 Intermediate Similarity NPD6118 Approved
0.7222 Intermediate Similarity NPD6695 Phase 3
0.7196 Intermediate Similarity NPD6868 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data